Evidence map›Paper›PMID 37651090›Full record

ReviewTissue engineering and regenerative medicine2023

Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine.

Maria Ruth Pineda-Cortel, Consuelo Suarez, Jan-Tyrone Cabrera, Minerva Daya, Mary Monica Bernardo-Bueno, Renz Cleve Vergara, Adrian Villavieja

Abstract readReview
In one paragraph

Review in Tissue engineering and regenerative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Platelet-Rich Plasma for Rhinitis Medicamentosa: A Promising Histopathological Study in an Animal Model.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Ruth Pineda-CortelDepartment of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Consuelo SuarezFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Jan-Tyrone CabreraFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
Minerva DayaDepartment of Biochemistry, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines.
Mary Monica Bernardo-BuenoOur Lady of Lourdes Hospital, Manila, Philippines.
Renz Cleve VergaraResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines.
Adrian VillaviejaResearch Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines. adrian.villavieja.gs@ust.edu.ph.ORCID http://orcid.org/0000-0002-4308-7017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlatelet-rich plasma (PRP), a blood-based product containing platelets and growth factors, is being utilized to treat numerous non-hemostatic disorders. Studies have explored the use of PRP to provide rapid repair, healing, and recovery from various injuries; some studies mentioned the effectiveness of PRP as compared with other forms of treatment like the use of hyaluronic acid. Commercially available PRP systems are available now, and each varies from one another depending on how it is prepared, thus causing variations in platelet concentration and growth factor content. These variations also implicated different therapeutic applications.

methodsThe paper reviews the various applications of PRP, including factors to consider before using PRP therapy, and provides an extensive list of PRP applications.

resultsThe administration of PRP as a standalone treatment or as a co-therapy results in observed positive outcomes. However, there is a lack of standardization for PRP preparation, increasing the risks for heterogeneity and bias amongst results.

conclusionThe use of PRP is indeed an option for regenerative therapy, but more research is needed before it can fully be recommended as a primary treatment modality.

Indexed as

Platelet-Rich PlasmaRegenerative MedicineHyaluronic AcidHyaluronic AcidBiotherapyPlateletPlatelet-rich plasmaRegenerative medicineTreatment

Identifiers

PMID37651090
PMCPMC10519926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.